Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Aptorum Group Limited

Aptorum Group is a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We have obtained exclusive licenses for our technologies. In addition, we are also developing certain proprietary technologies as product candidates. We are pursuing therapeutic and diagnostic projects (including projects seeking to use extracts or derivatives from natural substances to treat diseases) in neurology, infectious diseases, gastroenterology, oncology and other disease areas.

  • Date:Monday, February 11
  • Time:9:30 AM - 9:45 AM
  • Room:Herald/Soho
  • Location:7th Floor
  • Session Type:Company Presentation
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Submission ID:23574
  • Goal for Presentation:Promote the company
  • Company Website:www.aptorumgroup.com
  • Company HQ City:Hong Kong
  • Company HQ Country:Hong Kong
  • Ticker:APM
  • Exchange:Nasdaq
  • CEO/Top Company Official:Ian Huen
  • Year Founded:2010
  • Main Therapeutic Focus:Infectious Diseases
  • Lead Product in Development:Small molecule for the treatment of MRSA and influenza virus A
  • Development Phase of Primary Product:Pre-Clinical
  • Additional Information/Comments:CEO Mr. Ian Huen would not be attending the event. Ms. Sabrina Khan and Dr. Thomas Lee, our Chief Scientific Officer, would be presenting instead.
Speakers
Sabrina Khan
Aptorum Group Limited
Thomas Lee
Aptroum Group Limited
Back